Exploring the role of progestins and phytoestrogens in menopause

Hale, Georgina E.; Bievre, Marsha; Hughes, Claude L.

doi:10.1016/s1096-2190(00)00011-1

Cited by 5 publications

(4 citation statements)

References 77 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 During this period, women always experience many metals distresses, such as poor concentration, agitation, anxiety, depression, and difficulty controlling themselves. 2,3 Depression was one of the most common and specific symptoms of menopause, [4][5][6] which may cause some serious problems such as disability and death, 7,8 leading to significant individual, family, and society burdens. 9 Oestrogen is the most used to treat depression and for relieving other symptoms among menopausal women in clinical.…”

Section: Introductionmentioning

confidence: 99%

Efficacy and safety of phytoestrogens in the treatment of perimenopausal and postmenopausal depressive disorders: A systematic review and meta‐analysis

Yan

et al. 2021

Int J Clin Pract

View full text Add to dashboard Cite

Background: Depression is one of the most common and specific symptoms among menopausal women, leading to significant personal, family, and economic burdens. Some studies have shown that phytoestrogens can help relieve symptoms of depression.Objectives:This systematic review and meta-analysis aim to assess the efficacy and safety of phytoestrogens in treating depression among menopausal women. Methods: A comprehensive search for relevant studies published until November 25, 2020, was conducted in PubMed, the Cochrane Library, Chinese Biomedical Literature Database, Web of Science, and EMBASE. Statistical analyses were performed with R 4.0.3.and Review Manager 5.4.Results:2183 studies were identified and 10 studies with 15 independent reports were included, involving 1248 participants. The quality of the four studies was assessed as high risk, six studies were assessed as unclear. The analyses conducted according random effects model indicated the significant positive effect on depressive symptoms for postmenopausal women compared with the placebo (SMD = −0.62; 95% CI = −1.13 to −0.12; Q = 45.62, df = 14, P < .01; I 2 = 79%). The low dose phytoestrogens (25 mg/d ≤ dose ≤ 100 mg/d) have better effectiveness (SMD = −0.52; 95% CI = −0.85 to −0.20; I 2 = 79%, P< .01) than high dose (dose > 100 mg/d) and ultralow dose (0 < dose < 25 mg/d), but showed no statistical significance (Q = 0.81 df = 2, P = .67). Isoflavones had better effectiveness (SMD = −0.48; 95% CI = −0.75 to 0.21; I 2 = 75%, P < .01) than lignans of phytoestrogens (SMD = −0.22; 95% CI = −0.37 to 0.08; I 2 = 0%, P = .96). The duration of intervention affects the efficacy of phytoestrogens (β = −0.03; 95% CI: [−0.05, 0.00]; P = .045). The effectiveness varies in regions. The adverse reactions frequently reported were gastrointestinal symptoms and cold or upper respiratory tract infection. Conclusions:Phytoestrogen can relieve depression symptoms among menopausal, especially for postmenopausal women who take low doses(25 mg/d ≤ dose ≤ 100 mg/d) of phytoestrogens for a long-term duration. Although mild adverse reactions have been reported, phytoestrogen could be considered as a complementary treatment for postmenopausal depression.

show abstract

Section: Introductionmentioning

confidence: 99%

Efficacy and safety of phytoestrogens in the treatment of perimenopausal and postmenopausal depressive disorders: A systematic review and meta‐analysis

Yan

et al. 2021

Int J Clin Pract

View full text Add to dashboard Cite

show abstract

“…Menopause-related conditions are now a major public health concern 3 . The most common and specific symptoms of menopause include flushing, sudden sweating and chills, palpitations, feeling pressure in the head and chest, difficulty concentrating, and depression [4][5][6] . Depression is a common psychiatric disorder that can lead to disability and death 7,8 , causing substantial personal, family, social, and economic burdens 9 .…”

Section: Introductionmentioning

confidence: 99%

Effects of phytoestrogens in the treatment of postmenopausal depressive disorders: A systematic review and meta-analysis

Li¹,

Li²,

Yan³

et al. 2020

Preprint

View full text Add to dashboard Cite

Background:Menopause-related symptoms are now a major public health concern and depression is one of the most common and specific symptoms of post-menopause. Objectives: The purpose of this study was to assess the effectiveness of different kinds of phytoestrogens in the remission of depression for postmenopausal women. Methods: A comprehensive search for relevant studies published between January 1, 1951 and June 30, 2020 was conducted in PubMed, the Cochrane Library, Chinese Biomedical Literature Database, Web of Science and EMBASE. Endnote X9 was used for screening articles, the Stata12.0 and Review Manager 5.3 for analyzing data. Results: Phytoestrogens had a have a significant positive effect on depressive symptoms for climacteric women compared to the placebo (SMD=-0.51; 95% [CI]=-0.74 to-0.29; I2=72.4%; P<0.05). The effectiveness in isoflavones (SMD=-0.64; 95% [CI]=-0.97 to-0.32; I2=56.2%, P>0.05) is slightly better than non-isoflavones (SMD=-0.5; 95%[CI]=-93 to-0.07; I2=72.8%, P<0.05). The total intake of phytoestrogens in the high dose group was the most effective in alleviating the symptoms of postmenopausal depression (SMD=-0.69; 95%CI=-1.09 to-0.35, P<0.05). Postmenopausal women in Europe had the best improvement in efficacy after taking phytoestrogens (SMD=-0.72, 95% CI=-1.09 to-0.35, I2=65.5%, P<0.05). Conclusions: Our study demonstrated that phytoestrogen significantly reduce depression among postmenopausal women, with more effect for larger dosages. Phytoestrogen should be considered as a safe and effective complementary medicine for postmenopausal symptoms in place of estrogens.

show abstract

“…During this period, women always experience many metals distresses, such as poor concentration, agitation, anxiety, depression, and difficulty controlling themselves 2,3 . Depression was one of the most common and specific symptoms of menopause [4][5][6] , which may cause some serious problems such as disability and death 7,8 , leading to significant individual, family, and society burdens 9 .…”

Section: Introductionmentioning

confidence: 99%

Efficacy and safety of phytoestrogens in the treatment of postmenopausal depressive disorders: a systematic review and meta-analysis

Yan

et al. 2020

Preprint

View full text Add to dashboard Cite

Background：Depression is one of the most common and specific symptoms among postmenopausal women, leading to significant personal, family, and economic burdens. Some studies have shown that phytoestrogens can help relieve symptoms of depression. Objectives: This systematic review and meta-analysis aims to assess the efficacy and safety of phytoestrogens in treating depression among postmenopausal women. Methods: A comprehensive search for relevant studies published until November 25, 2020, was conducted in PubMed, the Cochrane Library, Chinese Biomedical Literature Database, Web of Science, and EMBASE. Statistical analyses were performed with Stata12.0, Comprehensive Meta-Analysis 3.0, and Review Manager 5.4. Results: 2,183 studies were identified and 10 studies were included, involving 1,248 participants. The quality of the four studies was assessed as high risk, six studies were assessed as unclear. The analyses conducted according random effects model indicated a positive effect on depressive symptoms for postmenopausal women compared to the placebo (SMD=-0.45; 95% [CI]= -0.60 to -0.29; Q=40.42, df=18, P=0.002; I2=55.5%). The high dose phytoestrogens (dose>100mg/day) have better effectiveness (SMD =-0.48; 95%[CI]= -0.76 to -0.20; I2=52.8%, P<0.05) than low dose (25mg/day≤dose≤100mg/day) (SMD=-0.45; 95%[CI]=-0.68 to-0.23; I2=66.7%; P>0.05) and ultralow dose (00.05). Isoflavones had better effectiveness (SMD=-0.52; 95% [CI]= -0.75 to 0.30; I2=65.8%, P<0.05) than lignans of phytoestrogens (SMD= -0.23; 95% [CI]= -0.05 to 0.01; I2=0%, P>0.05). The effectiveness varies in regions. The adverse reactions frequently reported were gastrointestinal symptoms and cold or upper respiratory tract infection. Conclusions: Phytoestrogen can relieve depression symptoms among postmenopausal women. High-dose isoflavones is the most effective. Although mild adverse reactions have been reported, phytoestrogen could be considered as a complementary treatment for postmenopausal depression.

show abstract

Exploring the role of progestins and phytoestrogens in menopause

Cited by 5 publications

References 77 publications

Efficacy and safety of phytoestrogens in the treatment of perimenopausal and postmenopausal depressive disorders: A systematic review and meta‐analysis

Efficacy and safety of phytoestrogens in the treatment of perimenopausal and postmenopausal depressive disorders: A systematic review and meta‐analysis

Effects of phytoestrogens in the treatment of postmenopausal depressive disorders: A systematic review and meta-analysis

Efficacy and safety of phytoestrogens in the treatment of postmenopausal depressive disorders: a systematic review and meta-analysis

Contact Info

Product

Resources

About